3,123 Shares of Astera Labs, Inc. $ALAB Acquired by Howard Capital Management LLC

Howard Capital Management LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the 3rd quarter, Holdings Channel reports. The firm purchased 3,123 shares of the company’s stock, valued at approximately $1,112,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Keating Financial Advisory Services Inc. purchased a new position in shares of Astera Labs during the 2nd quarter worth about $25,000. Archer Investment Corp acquired a new stake in shares of Astera Labs in the second quarter worth approximately $30,000. Transamerica Financial Advisors LLC acquired a new stake in shares of Astera Labs in the second quarter worth approximately $35,000. Continuum Advisory LLC acquired a new stake in shares of Astera Labs in the second quarter worth approximately $37,000. Finally, GK Wealth Management LLC acquired a new stake in shares of Astera Labs in the third quarter worth approximately $29,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Trading Down 5.4%

ALAB stock opened at $285.82 on Friday. The stock has a 50-day moving average price of $314.86 and a two-hundred day moving average price of $297.01. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The company has a market cap of $49.59 billion, a PE ratio of 141.50 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The firm’s revenue was up 104.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts forecast that Astera Labs, Inc. will post 2.70 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the sale, the general counsel owned 96,542 shares in the company, valued at approximately $32,872,551. The trade was a 6.58% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the sale, the director owned 253,863 shares of the company’s stock, valued at $71,114,642.19. The trade was a 41.89% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 408,558 shares of company stock worth $127,306,034. 10.40% of the stock is owned by insiders.

Analyst Ratings Changes

ALAB has been the subject of a number of recent analyst reports. Bank of America boosted their target price on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Weiss Ratings raised shares of Astera Labs from a “hold (c)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Jefferies Financial Group increased their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Royal Bank Of Canada lifted their price target on shares of Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Finally, Zacks Research lowered shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Eleven investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and an average target price of $348.33.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.